Table 1_A fully integrated sample-to-answer molecular diagnostic platform for rapid identi

A validation dataset for a fully automated PCR-based diagnostic platform, authored by Eun Hae Oh and last updated in 2026. It contains results from analytical and clinical feasibility studies comparing the platform's performance against MALDI-TOF for identifying four major Aspergillus species.

Use Cases

• Validate diagnostic assay performance based on comparison with MALDI-TOF results mentioned in the description
• Analyze species-level identification accuracy for Aspergillus fumigatus, flavus, niger, and terreus based on the platform's targets
• Assess clinical feasibility for diagnosing invasive pulmonary aspergillosis based on results from bronchoalveolar lavage samples

Strengths

• Performance metrics are provided, including 95.2% overall agreement with MALDI-TOF for culture isolates
• Clinical validation includes 22 patient bronchoalveolar lavage specimens from proven and probable IPA cases
• The dataset is published under a CC-BY-4.0 license for open reuse

Limitations

• The dataset is small (441.7 KB), suggesting limited scope
• Column-level documentation is absent; field semantics must be inferred after download
• Row count is unknown, which may limit suitability assessment

Provenance

Source

figshare

Collection Method

Data likely generated from analytical consistency testing and clinical feasibility validation studies described in the associated paper.

Freshness

Last updated 2026-05-26 05:25:52; freshness should be verified